PERMANENT AWARD EVIDENCE

Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies

East Midlands Pharmacy Collaborative · published 7 May 2025. This page preserves the identifiers and current held fields for one Contracts Finder release; it is not an invoice, performance assessment or complete contract history.

Open official source ↗More from this buyer

Contracts Finder release IDee03e54b-8a5c-4058-a614-0eeb9ddb5f73-843938

Open Contracting ID (OCID)ocds-b5fd17-e8653637-3725-450a-adef-4614a52dc955

Buyer identifierGB-CFS-282503

Release typeaward

PUBLISHED COMMERCIAL FIELDS

Values stay separate.

A tender estimate and an award value answer different questions. Neither is treated as cash paid.

Award value: £2,760,000
Tender value: Not disclosed
Procurement method: Open procedure (above threshold)
Category: services
CPV: 85100000
Delivery: United Kingdom

PUBLISHED DESCRIPTION

What the notice says

This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities

Tender statuscomplete

STAGE-DATE LEDGER

Reported dates, without an invented lifecycle.

The current projection contains one award release, not a verified chain of planning, tender, award, contract and modification records. Dates are shown in source-field order and are not silently repaired.

01Notice publishedPublication timestamp on the held release7 May 2025
02Tender period endsTender-period field as published11 Oct 2024
03Contract startsContract-period field as published30 Apr 2025
04Contract endsContract-period field as published30 Apr 2027

SUPPLIER EVIDENCE

Published names and exact identifiers

A company profile appears only when this release carries a usable company number. Name-only suppliers remain name-only.

Published name only